Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | ACACB | O00763 | 1/20 | 0.36 |
| ▸ | ACACA | Q13085 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.33 |
| ▸ | ACLY | P53396 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18418937 | 0.84 | ACACB (0.35) | ALDH1A1TSHRACACBACACACYP2C19 | |
| SCHEMBL1691839 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TSHRLCKPPARDZDHHC20 | |
| SCHEMBL11022237 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TSHRLCKPPARDZDHHC20 | |
| SCHEMBL6897321 | 0.80 | ALDH1A1 (0.48) | ALDH1A1TSHRLCKPPARDZDHHC20 | |
| SCHEMBL29169946 | 0.80 | ACACB (0.39) | ALDH1A1TSHRACACBACACATHRB | |
| SCHEMBL9688268 | 0.78 | ACACB (0.38) | ALDH1A1TSHRACACBACACATHRB | |
| SCHEMBL23250239 | 0.76 | ALDH1A1 (0.44) | ALDH1A1TSHRLCKPPARDZDHHC20 | |
| SCHEMBL20100216 | 0.74 | ALDH1A1 (0.34) | ALDH1A1TSHRLCKPPARDZDHHC20 | |
| SCHEMBL28552427 | 0.74 | ACACB (0.41) | ALDH1A1TSHRACACBACACACYP2C19 | |
| SCHEMBL7698226 | 0.73 | ACACB (0.42) | ALDH1A1TSHRACACBACACAACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3498755-B1 | FULLERENE DERIVATIVE AND LUBRICANT | SHOWA DENKO KK (JP) | 2021-05-12 | — | — | EP | disclosed |
| US-10738260-B2 | Fullerene derivative and lubricant | SHOWA DENKO K.K. (JP) | 2020-08-11 | — | — | US | disclosed |
| US-20190203140-A1 | FULLERENE DERIVATIVE AND LUBRICANT | RESONAC CORPORATION (JP) | 2019-07-04 | — | — | US | disclosed |
| EP-3498755-A1 | FULLERENE DERIVATIVE AND LUBRICANT | Showa Denko K.K. (JP) | 2019-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10738260-B2 | Fullerene derivative and lubricant | FLNA, FLNB, FSCN1 | ALDH1A1 1046/4885TSHR 2385/4885LCK 1537/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.